Business Segments Boston Scientific Corporation
Equities
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 97.52 USD | -0.20% |
|
-4.00% | +9.18% |
| 12-02 | Boston Scientific Insider Sold Shares Worth $1,758,189, According to a Recent SEC Filing | MT |
| 12-02 | Aclarion, Inc. Appoints Jason Brosniak as Commercial Director for the Eastern U.S | CI |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Therapeutic Devices | ||||||||||
Cardiovascular (Incl. Rhythm) | 3.88B | 4.86B | 7.83B | 8.82B | 10.76B | |||||
Total Assets | 2.46B | 2.82B | 5.2B | 5.99B | 7.08B | |||||
D&A | 154M | 167M | 245M | 263M | 302M | |||||
Operating Income | 661M | 1.45B | 2.11B | 2.24B | 3.15B | |||||
Med Surg | 3.07B | 3.72B | 4.91B | 5.42B | 5.99B | |||||
Total Assets | 1.64B | 1.79B | 2.5B | 2.89B | 3.09B | |||||
D&A | 80M | 81M | 88M | 103M | 110M | |||||
Operating Income | 1.08B | 1.4B | 1.62B | 1.8B | 2.05B | |||||
Rhythm and Neuro | 2.75B | 3.29B | - | - | - | |||||
Total Assets | 1.83B | 1.98B | - | - | - | |||||
D&A | 96M | 104M | - | - | - | |||||
Operating Income | 439M | 607M | - | - | - | |||||
Rhythm Management | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Pharmaceutical Products | ||||||||||
Specialty Pharmaceuticals | 219M | 13M | - | - | - | |||||
Total Assets | 1.13B | - | - | - | - | |||||
D&A | 3M | - | - | - | - | |||||
Operating Income | 143M | 4M | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Other | - | - | -60M | - | - | |||||
Operating Income | - | - | -60M | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | -405M | -447M | -436M | -293M | -663M | |||||
Total Assets | 9.95B | 11.99B | 12.92B | 14.39B | 17.09B | |||||
Total Assets | 5.92B | 6.12B | 5.9B | 6B | 6.68B | |||||
Total Assets | 7.85B | 7.52B | 5.94B | 5.87B | 5.45B |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
United States (U.S.) | 5.7B | 6.91B | 7.63B | 8.42B | 10.21B | |||||
Total Assets | 1.15B | 1.19B | 1.24B | 1.3B | 1.46B | |||||
Europe, Middle East and Africa (EMEA) | 2.1B | 2.52B | 2.53B | 2.86B | 3.23B | |||||
Asia-Pacific (APAC) | 1.78B | 2.07B | 2.12B | 2.4B | 2.69B | |||||
Latin America and Canada (LACA) | 307M | 386M | 469M | 560M | 624M | |||||
Total Assets | 16.33B | 18.54B | 19.21B | 20.83B | 24.22B | |||||
Total Assets | - | - | 246M | 373M | 530M | |||||
International | 27M | 4M | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Other Countries | - | - | -60M | - | - | |||||
Total Assets | 551M | 625M | 481M | 587M | 672M | |||||
Total Assets | 382M | 436M | 478M | 598M | 631M | |||||
Japan | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - |
- Stock Market
- Equities
- BSX Stock
- Financials Boston Scientific Corporation
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition